Targeting neurotensin as a potential novel approach for the treatment of autism

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Ghanizadeh, Ahmad ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; NEUROTENSIN;

4 AMINOBUTYRIC ACID RELEASE; APOPTOSIS; AUTISM; GABAERGIC SYSTEM; HUMAN; INFLAMMATION; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; NOTE; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; BLOOD; CHILD;

AUTISTIC DISORDER; CHILD; HUMANS; NEUROTENSIN;

EID: 77957200346     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-58     Document Type: Note

References (15)

1. Angelidou A, Francis K, Vasiadi M, Alysandratos KD, Zhang B, Theoharides A, Lykouras L, Sideri K, Kalogeromitros D, Theoharides TC. Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation 7(1):48. 10.1186/1742-2094-7-48, 2936302, 20731814.
2. Antonelli T, Ferraro L, Fuxe K, Finetti S, Fournier J, Tanganelli S, De Mattei M, Tomasini MC. Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity. Cereb Cortex 2004, 14(4):466-473. 10.1093/cercor/bhh008, 15028650.
3. Ferraro L, Tomasini MC, Mazza R, Fuxe K, Fournier J, Tanganelli S, Antonelli T. Neurotensin receptors as modulators of glutamatergic transmission. Brain Res Rev 2008, 58(2):365-373. 10.1016/j.brainresrev.2007.11.001, 18096238.
4. Antonelli T, Fuxe K, Tomasini MC, Mazzoni E, Agnati LF, Tanganelli S, Ferraro L. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment. Prog Neurobiol 2007, 83(2):92-109. 10.1016/j.pneurobio.2007.06.006, 17673354.
5. Liu Z, Qiu YH, Li B, Ma SH, Peng YP. Neuroprotection of Interleukin-6 Against NMDA-Induced Apoptosis and Its Signal-Transduction Mechanisms. Neurotox Res
6. Shinohe A, Hashimoto K, Nakamura K, Tsujii M, Iwata Y, Tsuchiya KJ, Sekine Y, Suda S, Suzuki K, Sugihara G, et al. Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(8):1472-1477. 10.1016/j.pnpbp.2006.06.013, 16863675.
7. Chez MG, Burton Q, Dowling T, Chang M, Khanna P, Kramer C. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 2007, 22(5):574-579. 10.1177/0883073807302611, 17690064.
8. Mitchell VA, Kawahara H, Vaughan CW. Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey. J Physiol 2009, 587(Pt 11):2511-2520. 10.1113/jphysiol.2008.167429, 2714017, 19359367.
9. Petkova-Kirova P, Rakovska A, Della Corte L, Zaekova G, Radomirov R, Mayer A. Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis. Brain Res Bull 2008, 77(2-3):129-135. 10.1016/j.brainresbull.2008.04.003, 18721670.
10. Petrie KA, Schmidt D, Bubser M, Fadel J, Carraway RE, Deutch AY. Neurotensin activates GABAergic interneurons in the prefrontal cortex. J Neurosci 2005, 25(7):1629-1636. 10.1523/JNEUROSCI.3579-04.2005, 15716398.
11. Li S, Geiger JD, Lei S. Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels. J Neurophysiol 2008, 99(5):2134-2143. 10.1152/jn.00890.2007, 18337367.
12. Jolicoeur FB, Gagne MA, Rivest R, Drumheller A, St-Pierre S. Atypical neuroleptic-like behavioral effects of neurotensin. Brain Res Bull 1993, 32(5):487-491. 10.1016/0361-9230(93)90295-M, 8106129.
13. Rostene W, Azzi M, Boudin H, Lepee I, Souaze F, Mendez-Ubach M, Betancur C, Gully D. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions. Ann N Y Acad Sci 1997, 814:125-141. 10.1111/j.1749-6632.1997.tb46151.x, 9160965.
14. Harada M, Taki MM, Nose A, Kubo H, Mori K, Nishitani H, Matsuda T. Non-Invasive Evaluation of the GABAergic/Glutamatergic System in Autistic Patients Observed by MEGA-Editing Proton MR Spectroscopy Using a Clinical 3 Tesla Instrument. J Autism Dev Disord 2010, ePub.
15. Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD. GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 2009, 39(2):223-230. 10.1007/s10803-008-0646-7, 2697059, 18821008.